Equity Research, Broker Reports, and media content on MaxCyte, Inc.

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about MaxCyte, Inc.
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

MaxCyte, Inc.

Company Profile

  • Personnel
  • Doug Doerfler , CEO
  • Ron Holtz, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on MaxCyte, Inc.. We currently have 100 research reports from 7 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 380/1235p
  • Daily Volume: N/A
  • Daily Liquidity: (0.03%)
  • # Shares: 100.4m
  • Market Cap: £773.3m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
06Oct21 07:00 RNS MaxCyte, Inc. - Holdings in Company
01Oct21 15:49 RNS MaxCyte, Inc. - Notice of AGM and Change of Director
01Oct21 12:36 RNS MaxCyte, Inc. - Total Voting Rights
17Sep21 14:35 RNS MaxCyte, Inc. - MaxCyte Set to Join Russell 2000® Index
14Sep21 07:00 RNS MaxCyte, Inc. - Half-year Report
14Sep21 07:00 RNS MaxCyte, Inc. - Filing of Form 10-Q
06Sep21 17:21 RNS MaxCyte, Inc. - Issue of Equity and Total Voting Rights
  • Frequency of research reports


  • Research reports on

    MaxCyte, Inc.

  • Providers covering

    MaxCyte, Inc.